Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|May 19, 2011
Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patientsShozo Ohsumi, Takeshi Inoue, Sachiko Kiyoto, et al.
Case Reports in Oncology|August 27, 2010
Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine TherapyFumikata Hara, Sachiko Kiyoto, Daisuke Takabatake, et al.
Bioscience, Biotechnology, and Biochemistry|August 24, 2005
Gene transfection into HeLa cells by vesicles containing cationic peptide lipidYumi Ohama, Yuji Heike, Takuya Sugahara, et al.
Breast Cancer (Tokyo, Japan)|August 20, 2005
Two cases with long-term disease-free survival after resection and radiotherapy for solitary brain metastasis from breast cancer with extensive nodal metastasesShinsuke Saisho, Shigemitsu Takashima, Shozo Ohsumi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 23, 2009
Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patientsMasayo Suzuki, Hiroyuki Ishida, Yukimasa Shiotsu, et al.
Anti-Cancer Drugs|July 3, 2008
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in JapanNahomi Tokudome, Yoshinori Ito, Kiyohiko Hatake, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|June 26, 2003
[Results of accelerated hyperfractionated radiotherapy in breast conserving therapy: a pilot study]Masaaki Kataoka, Shuichi Shinohara, Takashi Ochi, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2010
The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotypeKenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, et al.
Anticancer Research|February 26, 2004
Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasiaNagio Takigawa, Mikiko Ida, Yoshihiko Segawa, et al.
Cancer Chemotherapy and Pharmacology|July 11, 2002
Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancerGyo Asai, Nobuyuki Yamamoto, Masakazu Toi, et al.
Pageof 10